Dana Investment Advisors Inc. trimmed its holdings in Danaher Co. (NYSE:DHR) by 15.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 12,064 shares of the conglomerate’s stock after selling 2,255 shares during the quarter. Dana Investment Advisors Inc.’s holdings in Danaher were worth $1,244,000 at the end of the most recent reporting period.

A number of other large investors have also bought and sold shares of DHR. Oregon Public Employees Retirement Fund boosted its holdings in Danaher by 10,085.3% in the fourth quarter. Oregon Public Employees Retirement Fund now owns 6,863,048 shares of the conglomerate’s stock valued at $67,000 after purchasing an additional 6,795,666 shares during the last quarter. Renaissance Technologies LLC boosted its holdings in Danaher by 87.4% in the third quarter. Renaissance Technologies LLC now owns 3,219,500 shares of the conglomerate’s stock valued at $349,831,000 after purchasing an additional 1,501,300 shares during the last quarter. Findlay Park Partners LLP boosted its holdings in Danaher by 25.0% in the fourth quarter. Findlay Park Partners LLP now owns 4,595,000 shares of the conglomerate’s stock valued at $473,836,000 after purchasing an additional 920,000 shares during the last quarter. AQR Capital Management LLC boosted its holdings in Danaher by 48.2% in the third quarter. AQR Capital Management LLC now owns 2,682,662 shares of the conglomerate’s stock valued at $291,498,000 after purchasing an additional 872,626 shares during the last quarter. Finally, FMR LLC boosted its holdings in Danaher by 3.5% in the third quarter. FMR LLC now owns 21,739,751 shares of the conglomerate’s stock valued at $2,362,241,000 after purchasing an additional 728,725 shares during the last quarter. 78.29% of the stock is currently owned by institutional investors.

DHR has been the topic of several recent analyst reports. Jefferies Financial Group increased their target price on shares of Danaher to $140.00 and gave the stock a “buy” rating in a research note on Tuesday, February 26th. Needham & Company LLC initiated coverage on shares of Danaher in a research note on Wednesday, January 2nd. They set a “buy” rating and a $114.00 target price on the stock. JPMorgan Chase & Co. reissued an “overweight” rating and set a $140.00 target price on shares of Danaher in a research note on Monday, March 4th. Janney Montgomery Scott raised shares of Danaher from a “neutral” rating to a “buy” rating in a research note on Monday, February 25th. Finally, UBS Group increased their target price on shares of Danaher from $125.00 to $144.00 and gave the stock a “buy” rating in a research note on Tuesday, February 26th. Two research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus price target of $123.31.

In related news, CAO Robert S. Lutz sold 15,000 shares of the firm’s stock in a transaction dated Sunday, February 24th. The shares were sold at an average price of $127.00, for a total value of $1,905,000.00. Following the transaction, the chief accounting officer now directly owns 22,251 shares of the company’s stock, valued at approximately $2,825,877. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, SVP Angela S. Lalor sold 4,534 shares of the firm’s stock in a transaction dated Wednesday, February 27th. The shares were sold at an average price of $127.25, for a total transaction of $576,951.50. Following the completion of the transaction, the senior vice president now directly owns 21,209 shares in the company, valued at $2,698,845.25. The disclosure for this sale can be found here. Insiders sold a total of 183,150 shares of company stock worth $23,279,637 over the last ninety days. 11.90% of the stock is currently owned by corporate insiders.

DHR stock opened at $128.69 on Friday. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.07 and a current ratio of 1.47. Danaher Co. has a 52-week low of $94.59 and a 52-week high of $129.42. The stock has a market cap of $90.32 billion, a PE ratio of 28.47, a PEG ratio of 2.35 and a beta of 1.04.

Danaher (NYSE:DHR) last posted its earnings results on Tuesday, January 29th. The conglomerate reported $1.28 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.27 by $0.01. The business had revenue of $5.40 billion for the quarter, compared to analyst estimates of $5.33 billion. Danaher had a net margin of 13.33% and a return on equity of 11.64%. The company’s revenue for the quarter was up 6.2% on a year-over-year basis. During the same period in the prior year, the company posted $1.19 EPS. Sell-side analysts forecast that Danaher Co. will post 4.76 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Friday, April 26th. Investors of record on Friday, March 29th will be paid a $0.17 dividend. The ex-dividend date is Thursday, March 28th. This is a positive change from Danaher’s previous quarterly dividend of $0.16. This represents a $0.68 dividend on an annualized basis and a yield of 0.53%. Danaher’s dividend payout ratio (DPR) is currently 14.16%.

WARNING: “Dana Investment Advisors Inc. Sells 2,255 Shares of Danaher Co. (DHR)” was first published by Daily Political and is the property of of Daily Political. If you are viewing this news story on another site, it was stolen and reposted in violation of international trademark & copyright law. The original version of this news story can be read at https://www.dailypolitical.com/2019/03/17/dana-investment-advisors-inc-sells-2255-shares-of-danaher-co-dhr.html.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.

Recommended Story: What is Compound Interest?

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.